EUVIMEDEUVIMED entdecken
Crossref

MicroRNA‐431‐5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF‐β1/SMAD2/3 signaling via ZEB1 in gastric cancer

Pengpeng Liu iD, Ping'an Ding, Jiaxuan Yang, Haotian Wu, Jiaxiang Wu, Honghai Guo, Peigang Yang, Yuan Tian, Lingjiao Meng, Qun Zhao

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Pengpeng Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, MicroRNAs, Lymphatic Metastasis, Lymphangiogenesis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Hebei Provincial Government-funded Clinical Talent Project, Hebei Provincial Major Science and Technology Special Project, Beijing-Tianjin-Hebei Basic Research Cooperation Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulating evidence suggests that lymphangiogenesis plays a crucial role in lymphatic metastasis, leading to tumor immune tolerance. However, the specific mechanism remains unclear. In this study, miR‐431‐5p was markedly downregulated in both gastric cancer (GC) tissues and plasma exosomes, and its expression were correlated negatively with LN metastasis and poor prognosis. Mechanistically, miR‐431‐5p weakens the TGF‐β1/SMAD2/3 signaling pathway by targeting ZEB1, thereby suppressing the secretion of VEGF‐A and ANG2, which in turn hinders angiogenesis, lymphangiogenesis, and lymph node (LN) metastasis in GC. Experiments using a popliteal LN metastasis model in BALB/c nude mice demonstrated that miR‐431‐5p significantly reduced popliteal LN metastasis. Additionally, miR‐431‐5p enhances the efficacy of anti‐PD1 treatment, particularly when combined with galunisertib, anti‐PD1 treatment showing a synergistic effect in inhibiting GC progression in C57BL/6 mice. Collectively, these findings suggest that miR‐431‐5p may modulate the TGF‐β1/SMAD2/3 pathways by targeting ZEB1 to impede GC progression, angiogenesis, and lymphangiogenesis, making it a promising therapeutic target for GC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsMicroRNAsLymphatic MetastasisLymphangiogenesisNeovascularization, PathologicTransforming Growth Factor beta1Zinc Finger E-box-Binding Homeobox 1Smad3 ProteinGene Expression Regulation, NeoplasticSignal TransductionSmad2 ProteinMice, Inbred BALB CHumansAnimalsMiceMice, NudeMaleFemaleCell Line, TumorMice, Inbred C57BLPrognosisMiddle AgedAngiogenesis

Stichwörter der Autor:innen

angiogenesisgastric cancerimmune tolerancelymphangiogenesismiR‐431‐5p

Substanzen

MicroRNAsTransforming Growth Factor beta1Zinc Finger E-box-Binding Homeobox 1Smad3 ProteinZEB1 protein, humanSmad2 ProteinSMAD3 protein, humanSMAD2 protein, humanTGFB1 protein, human

Autor:innen und Institutionen

  • The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Hebei Key Laboratory of Precision Diagnosis and Comprehensive Treatment of Gastric Cancer, Shijiazhuang, Hebei, China.
  • Big data analysis and mining application for precise diagnosis and treatment of gastric cancer Hebei Provincial Engineering Research Center, Shijiazhuang, Hebei, China.
  • Research Center and Tumor Research Institute of the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

ORCID-Profile: Pengpeng Liu

Förderung

  • Hebei Provincial Government-funded Clinical Talent Project
  • Hebei Provincial Major Science and Technology Special Project
  • Beijing-Tianjin-Hebei Basic Research Cooperation Special Project

Zitieren

APA

Liu, P., Ding, P., Yang, J., Wu, H., Wu, J., Guo, H., Yang, P., Tian, Y., Meng, L., & Zhao, Q. (2024). MicroRNA‐431‐5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF‐β1/SMAD2/3 signaling via ZEB1 in gastric cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23731

Vancouver

Liu P, Ding P, Yang J, Wu H, Wu J, Guo H, et al. MicroRNA‐431‐5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF‐β1/SMAD2/3 signaling via ZEB1 in gastric cancer. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23731

BibTeX
@article{Liu2024,
  author = {Liu, Pengpeng and Ding, Ping'an and Yang, Jiaxuan and Wu, Haotian and Wu, Jiaxiang and Guo, Honghai and Yang, Peigang and Tian, Yuan and Meng, Lingjiao and Zhao, Qun},
  title = {MicroRNA‐431‐5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF‐β1/SMAD2/3 signaling via ZEB1 in gastric cancer},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23731}
}
Kostenlos starten →